exhibiting antitumor activity
and produced by Ube and currently marketed in the United States in cooperation with Eli Lilly and Company for acute coronary syndromes planned for percutaneous coronary intervention (PCI)
CAY10683 inhibits HDAC2 and HDAC6 with IC50 values of 0
InChiKey: FYZFQLYZABRFAZ-KUXGFVDGSA-N
4-dichlorophenyl)-3-hexyl-1H-1
DBCO-Maleimide nist III exhibiting antitumor activityDBCO Maleimide is a cleavable ADC linker used in the synthesis of antibody drug conjugates (ADCs). Product information CAS Number: 1395786 30 7 Molecular Weight: 427. 45 Formula: C25H21N3O4 Chemical Name: N (3 {2 azatricyclo[10. 4. 0. 0,]hexadeca 1(16),4,6,8,12,14 hexaen 10 yn 2 yl} 3 oxopropyl) 3 (2,5 dioxo 2,5 dihydro 1H pyrrol 1 yl)propanamide Smiles: O=C(CCNC(=O)CCN1C(=O)C=CC1=O)N1CC2=CC=CC=C2C#CC2=CC=CC=C12 InChiKey: NHFQNAGPXIVKND UHFFFAOYSA N